#Ophthalmology

2 articles tagged

Health•Oct 18

Key Ophthalmology Advances Unveiled at AAO 2025 Conference

The AAO 2025 conference showcased major ophthalmology updates, including positive 3-year data for a geographic atrophy drug and novel preclinical research on glaucoma.

By Dr. Kenji Tanaka

#Ophthalmology#AAO 2025#Glaucoma

Health•Oct 10

FDA Approves Eydenzelt, a Biosimilar for Eye Drug Eylea

The U.S. FDA has approved Eydenzelt, a biosimilar drug from Celltrion, for treating major retinal diseases like Wet AMD, offering a new, affordable option.

By Jessica Miller

#FDA Approval#Biosimilar#Celltrion

Related Tags

Key Ophthalmology Advances Unveiled at AAO 2025 Conference

FDA Approves Eydenzelt, a Biosimilar for Eye Drug Eylea